Dr Nella Cristina Fernandez, MD | |
2055 Normandie Dr, Montgomery, AL 36111-2732 | |
(334) 263-6228 | |
(334) 265-9136 |
Full Name | Dr Nella Cristina Fernandez |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 21 Years |
Location | 2055 Normandie Dr, Montgomery, Alabama |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023272168 | NPI | - | NPPES |
1023272168 | Medicaid | AL | |
017211900 | Medicaid | FL |
Facility Name | Location | Facility Type |
---|---|---|
Jackson Hospital & Clinic Inc | Montgomery, AL | Hospital |
Medical Center Enterprise | Enterprise, AL | Hospital |
Community Hospital Inc | Tallassee, AL | Hospital |
Troy Regional Medical Center | Troy, AL | Hospital |
Medical Center Barbour | Eufaula, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Alabama Pathology Associates | 8325026990 | 4 |
News Archive
Scientists at Oregon Health & Science University and the Oregon National Primate Research Center have successfully reprogrammed human skin cells to become embryonic stem cells capable of transforming into any other cell type in the body.
Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention.
In the past few years, several medications have been found to be contaminated with NDMA, a probable carcinogen. This chemical, which has also been found at Superfund sites and in some cases has spread to drinking water supplies, causes DNA damage that can lead to cancer.
As health insurers struggle with pricing resistance from employers and decreases in enrollment in group health employee benefit plans, health insurer growth and profitability continues to be under pressure, according to a new industry forecast by Conning Research & Consulting.
The extent to which protein targets are modulated by drugs or small molecule compounds depends on a number of factors, including the expression levels of the target, the effective concentration of the compound, and the time needed for the compound to perturb the target. To address these restrictions, researchers Abassi et al. (1) have devised a live cell morphological profiling approach for dynamic monitoring of the effect of small molecule compounds that was based on impedance measurement of cells with the xCELLigence RTCA System of Roche Applied Science.
› Verified 8 days ago
Entity Name | Alabama Pathology Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891786315 PECOS PAC ID: 8325026990 Enrollment ID: O20040709001153 |
News Archive
Scientists at Oregon Health & Science University and the Oregon National Primate Research Center have successfully reprogrammed human skin cells to become embryonic stem cells capable of transforming into any other cell type in the body.
Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention.
In the past few years, several medications have been found to be contaminated with NDMA, a probable carcinogen. This chemical, which has also been found at Superfund sites and in some cases has spread to drinking water supplies, causes DNA damage that can lead to cancer.
As health insurers struggle with pricing resistance from employers and decreases in enrollment in group health employee benefit plans, health insurer growth and profitability continues to be under pressure, according to a new industry forecast by Conning Research & Consulting.
The extent to which protein targets are modulated by drugs or small molecule compounds depends on a number of factors, including the expression levels of the target, the effective concentration of the compound, and the time needed for the compound to perturb the target. To address these restrictions, researchers Abassi et al. (1) have devised a live cell morphological profiling approach for dynamic monitoring of the effect of small molecule compounds that was based on impedance measurement of cells with the xCELLigence RTCA System of Roche Applied Science.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Nella Cristina Fernandez, MD 225b Winton M Blount Loop, Montgomery, AL 36117-3507 Ph: (334) 263-6228 | Dr Nella Cristina Fernandez, MD 2055 Normandie Dr, Montgomery, AL 36111-2732 Ph: (334) 263-6228 |
News Archive
Scientists at Oregon Health & Science University and the Oregon National Primate Research Center have successfully reprogrammed human skin cells to become embryonic stem cells capable of transforming into any other cell type in the body.
Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention.
In the past few years, several medications have been found to be contaminated with NDMA, a probable carcinogen. This chemical, which has also been found at Superfund sites and in some cases has spread to drinking water supplies, causes DNA damage that can lead to cancer.
As health insurers struggle with pricing resistance from employers and decreases in enrollment in group health employee benefit plans, health insurer growth and profitability continues to be under pressure, according to a new industry forecast by Conning Research & Consulting.
The extent to which protein targets are modulated by drugs or small molecule compounds depends on a number of factors, including the expression levels of the target, the effective concentration of the compound, and the time needed for the compound to perturb the target. To address these restrictions, researchers Abassi et al. (1) have devised a live cell morphological profiling approach for dynamic monitoring of the effect of small molecule compounds that was based on impedance measurement of cells with the xCELLigence RTCA System of Roche Applied Science.
› Verified 8 days ago
Andrea Olofson, Pathology Medicare: Accepting Medicare Assignments Practice Location: 2055 Normandie Dr Ste 214, Montgomery, AL 36111 Phone: 334-263-6228 Fax: 334-265-9136 | |
Dr. Yvan Joseph Francillon, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 215 Perry Hill Rd, Pathology And Lab. Medicine 113p, Montgomery, AL 36109 Phone: 334-272-4670 Fax: 334-273-6200 | |
Ms. Kelley L Taylor, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 225b Winton M Blount Loop, Montgomery, AL 36117 Phone: 334-623-6228 Fax: 334-265-9136 | |
Dr. Timothy Clark Barrowman, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 225b Winton M Blount Loop, Montgomery, AL 36117 Phone: 334-263-6228 Fax: 334-265-9136 | |
Norman D Bell, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 215 Perry Hill Road, Montgomery, AL 36109 Phone: 334-272-4670 | |
Dr. Madhuri Singh, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 215 Perry Hill Rd, Montgomery, AL 36109 Phone: 334-272-4670 |